Perceptions of relative risk of disease and addiction from cigarettes and snus

Psychology of Addictive Behaviors

Volumn 28, Issue 2, 2014, Pages 367-375

  Lund, Ingeborg ^a   Scheffels, Janne ^a  

^a NORWEGIAN INSTITUTE FOR ALCOHOL AND DRUG RESEARCH   (Norway)

Author keywords

addiction; diseases; relative risks; smoking; snus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HEALTH BEHAVIOR; HEALTH HAZARD; HEALTH SURVEY; HUMAN; LUNG CANCER; MALE; MIDDLE AGED; MOUTH CANCER; NORWAY; RISK ASSESSMENT; RISK FACTOR; SELF CONCEPT; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; SMOKING HABIT; SNUS; STOMACH CANCER; TOBACCO DEPENDENCE; TOBACCO USE; YOUNG ADULT; ADDICTION; ATTITUDE TO HEALTH; AWARENESS; LUNG TUMOR; MOUTH TUMOR; PERCEPTION; PSYCHOLOGY; RISK; STATISTICS AND NUMERICAL DATA; STOMACH TUMOR; THINKING; TOBACCO;

ADOLESCENT; ADULT; AGED; AWARENESS; BEHAVIOR, ADDICTIVE; CARDIOVASCULAR DISEASES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NORWAY; PERCEPTION; RISK; SMOKING; SMOKING CESSATION; STOMACH NEOPLASMS; THINKING; TOBACCO PRODUCTS; TOBACCO USE DISORDER; TOBACCO, SMOKELESS; YOUNG ADULT;

EID: 84900002012     PISSN: 0893164X     EISSN: 19391501     Source Type: Journal    
DOI: 10.1037/a0032657     Document Type: Article

References (56)

1. Arnott, D. (2012). How can we bring an end to smoking? Guardian Professional. Retrieved from http://www.guardian.co.uk/healthcarenetwork/ 2012/may/31/end-smoking-no-tobacco-day
2. Bertuccio, P. L. A., Vecchia, C., Silverman, D. T., Petersen, G. M., Bracci, P. M., Negri, E., ⋯ Boffetta, P. (2011). Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: An analysis from the international pancreatic cancer case-control consortium (PanC4). Annals of Oncology, 22, 1420-1426. doi:10.1093/annonc/mdq613
3. Biener, L., & Bogen, K. (2009). Receptivity to Taboka and Camel Snus in a U.S. Test market. Nicotine and Tobacco Research, 11, 1154-1159. doi:10.1093/ntr/ntp113
4. Biener, L., McCausland, K., Curry, L., & Cullen, J. (2011). Prevalence of trial of snus products among adult smokers. American Journal of Public Health, 101, 1874-1876.
5. Bjartveit, K., & Tverdal, A. (2005). Health consequences of smoking 1-4 cigarettes per day. Tobacco Control, 14, 315-320. doi:10.1136/tc.2005 .011932
6. Boffetta, P., Hecht, S., Gray, N., Gupta, P., & Straif, K. (2008). Smokeless tobacco and cancer. Lancet Oncology, 9, 667-675. doi:10.1016/S1470- 2045(08)70173-6
7. Boffetta, P., & Straif, K. (2009). Use of smokeless tobacco and risk of myocardial infarction and stroke: Systematic review with meta-analysis. British Medical Journal, 339, b3060. doi:10.1136/bmj.b3060
8. Caldwell, B., Burgess, C., & Crane, J. (2010). Randomized crossover trial of the acceptability of snus, nicotine gum, and Zonnic therapy for smoking reduction in heavy smokers. Nicotine & Tobacco Research, 12, 179-183. doi:10.1093/ntr/ntp189
9. Cullen, J. W., Blot, W., Henningfield, J., Boyd, G., Mecklenburg, R., & Massey, M. M. (1986). Health consequences of using smokeless tobacco: Summary of the Advisory Committee's report to the Surgeon General. Public Health Reports, 101, 355-373.
10. DiFranza, J. R., Sweet, M., Savageau, J. A., & Ursprung, W. W. S. (2012). The assessment of tobacco dependence in young users of smokeless tobacco. Tobacco Control, 21, 471-476. doi:10.1136/tc.2011.043810
11. Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994). Mortality in relation to smoking: 40 years' observations on male British doctors. British Medical Journal, 309, 901. doi:10.1136/bmj.309.6959 .901
12. Foulds, J., Ramstrom, L., Burke, M., & Fagerstrom, K. (2003). Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tobacco Control, 12, 349-359. doi:10.1136/tc.12.4.349
13. Fuchs, C. S., Colditz, G. A., Stampfer, M. J., Giovannucci, E. L., Hunter, D. J., Rimm, E. B., ⋯ Speizer, F. E. (1996). A prospective study of cigarette smoking and the risk of pancreatic cancer. Archives of Internal Medicine, 156, 2255-2260. doi:10.1001/archinte.1996.00440180119015
14. Gandini, S., Botteri, E., Iodice, S., Boniol, M., Lowenfels, A. B., Maisonneuve, P., & Boyle, P. (2008). Tobacco smoking and cancer: A metaanalysis. International Journal of Cancer, 122, 155-164. doi:10.1002/ijc.23033
15. Gillies, V. (1999). An analysis of the discursive positions of women smokers. In C. Willig (Ed.), Applied Discourse analysis: Social and psychological interventions. Open University Press, Buckingham, U.K.
16. Hansson, J., Galanti, M. R., Hergens, M.-P., Fredlund, P., Ahlbom, A., Alfredsson, L., ⋯ Magnusson, C. (2012). Use of snus and acute myocardial infection: Pooled analysis of eight prospective observational studies. European Journal of Epidemiology, 27, 771-779. doi:10.1007/ s10654-012-9704-8
17. Hatsukami, D. K., Lemmonds, C., & Tomar, S. L. (2004). Smokeless tobacco use: Harm reduction or induction approach? Preventive Medicine, 38, 309-317. doi:10.1016/j.ypmed.2003.10.006
18. Heavner, K. K., Rosenberg, Z., & Phillips, C. V. (2009). Survey of smokers' reasons for not switching to safer sources of nicotine and their willingness to do so in the future. Harm Reduction Journal, 6, 14. doi:10.1186/1477-7517-6-14
19. Hecht, S. S. (1999). Tobacco smoke carcinogens and lung cancer. Journal of the National Cancer Institute, 91, 1194-1210. doi:10.1093/jnci/91.14 .1194
20. Hergens, M. P., Ahlbom, A., Andersson, T., & Pershagen, G. (2005). Swedish moist snuff and myocardial infarction among men. Epidemiology, 16, 12-16. doi:10.1097/01.ede.0000147108.92895.ba
21. IARC (International Agency for Research on Cancer). (2012). Smokeless tobacco and some tobacco specific N-nitrosamines. World Health Organization. Retrieved from http://monographs.iarc.fr/ENG/Monographs/ vol89/index.php
22. Johnson, J. L., Bottorff, J. L., Moffat, B., Ratner, P. A., Shoveller, J. A., & Lovato, C. Y. (2003). Tobacco dependence: Adolescents' perspectives on the need to smoke. Social Science and Medicine, 56, 1481-1492. doi:10.1016/S0277-9536(02)00150-8
23. Lee, P. N. (2011). Summary of the epidemiological evidence relating snus to health. Regulatory Toxicology and Pharmacology, 59, 197-214. doi: 10.1016/j.yrtph.2010.12.002
24. Lee, P. N., & Hamling, J. (2009). Systematic review of the relationship between smokeless tobacco and cancer in Europe and North America. BMC Medicine, 7, 36. doi:10.1186/1741-7015-7-36
25. Lund, I., & Scheffels, J. (2012). Perceptions of the relative harmfulness of snus among Norwegian general practitioners and their effect on the tendency to recommend snus in smoking cessation. Nicotine & Tobacco Research, 2, 169-175. doi:10.1093/ntr/ntr159
26. Lund, K. E. (2012). Association between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes. Nicotine & Tobacco Research, 14, 1221-1228. doi:10.1093/ntr/nts077
27. Lund, K. E., & McNeill, A. (2012). Patterns of dual use of snus and cigarettes in a mature snus market. Nicotine & Tobacco Research, 15, 678-684. doi:10.1093/ntr/nts185
28. Lund, K. E., McNeill, A., & Scheffels, J. (2010). The use of snus for quitting smoking compared with medicinal products. Nicotine & Tobacco Research, 12, 817-822. doi:10.1093/ntr/ntq105
29. Lund, K. E., Scheffels, J., & McNeill, A. (2011). The association between use of snus and quit rates for smoking: Results from seven Norwegian cross-sectional studies. Addiction, 106, 162-167. doi:10.1111/j.1360-0443.2010. 03122.x
30. Lunell, E., & Lunell, M. (2005). Steady-state nicotine plasma levels following use of four different types of Swedish snus compared with 2-mg Nicorette chewing gum: A crossover study. Nicotine and Tobacco Research, 7, 397-403. doi:10.1080/14622200500125468
31. Luo, J., Ye, W., Zendehdel, K., Adami, J., Adami, H.-O., Boffetta, P., & Nyrén, O. (2007). Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: A retrospective cohort study. Lancet, 369, 2015-2020. doi:10.1016/S0140-6736(07) 60678-3
32. Luoto, R., Uutela, A., & Puska, P. (2000). Occasional smoking increases total and cardiovascular mortality among men. Nicotine & Tobacco Research, 2, 133-139. doi:10.1080/713688127 O'Connor, R. J.
33. McNeill, A., Borland, R., Hammond, D., King, B., Boudreau, C., & Cummings, K. M. (2007). Smokers' beliefs about the relative safety of other tobacco products: Findings from the ITC Collaboration. Nicotine & Tobacco Research, 9, 1033-1042. doi:10.1080/ 14622200701591583
34. O'Loughlin, J., Kishchuk, N., Difranza, J., Tremblay, M., & Paradis, G. (2002). The hardest thing is the habit; a qualitative investigation of adolescent smokers' experience of nicotine dependence. Nicotine & Tobacco Research, 4, 201-209. doi:10.1080/14622200210123000
35. Opinion. (2002). Snusing og helseeffekt, Rapport til den Norske Legeforeningen [Snus use and health effects. Report to the Norwegian Medical Association] Opinion, Oslo, Norway.
36. Osterdahl, B. G., Jansson, C., & Paccou, A. (2004). Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. Journal of Agricultural and Food Chemistry, 52, 5085-5088. doi: 10.1021/jf049931a
37. Overland, S., Hetland, J., & Aaroe, L. E. (2008). Relative harm of snus and cigarettes: What do Norwegian adolescents say? Tobacco Control, 17, 422-425. doi:10.1136/tc.2008.026997
38. Parry, O., Fowkes, F. G. R., & Thomson, C. (2001). Accounts of quitting among older ex-smokers with smoking-related disease. Journal of Health Psychology, 6, 481-493. doi:10.1177/135910530100600502
39. Peiper, N., Stone, R., Van Zyl, R., & Rodu, B. (2010). University faculty perceptions of the health risks related to cigarettes and smokeless tobacco. Drug and Alcohol Review, 29, 121-130. doi:10.1111/j.1465-3362 .2009.000143.x
40. Pope III, C. A., Burnett, R. T., Turner, M. C., Cohen, A., Krewski, D., Jerrett, M., ⋯ Thun, M. J. (2011). Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: Shape of the exposure-response relationships. Environmental Health Perspectives, 119, 1616-1621. doi:10.1289/ehp.1103639
41. Post, A., Gilljam, H., Rosendahl, I., Bremberg, S., & Galanti, M. R. (2010). Symptoms of nicotine dependence in a cohort of Swedish youths: A comparison between smokers, smokeless tobacco users and dual tobacco users. Addiction, 105, 740-746. doi:10.1111/j.1360-0443.2009.02852.x
42. Rodu, B. (2011). The scientific foundation for tobacco harm reduction, 2006-2011. Harm Reduction Journal, 8, 19. doi:10.1186/1477-7517-8-19
43. Rodu, B., & Godshall, W. T. (2006). Tobacco harm reduction: An alternative cessation strategy for inveterate smokers. Harm Reduction Journal, 3, 37. doi:10.1186/1477-7517-3-37
44. Rodu, B., & Jansson, C. (2004). Smokeless tobacco and oral cancer: A review of the risks and determinants. Critical Reviews in Oral Biology & Medicine, 15, 252-263. doi:10.1177/154411130401500502
45. Rosenquist, K. (2005). Risk factors in oral and oropharyngeal squamous cell carcinoma: A population-based case-control study in southern Sweden. Swedish Dental Journal Supplement, 179, 1-66.
46. Royal College of Physicians. (2007). Harm reduction in nicotine addiction: Helping people who can't quit. A report by the Tobacco Advisory Group of the Royal College of Physicians, London: RCP. Retrieved from http://bookshop.rcplondon.ac.uk/
47. SCENIHR (Scientific Committee on Emerging and Newly-Identified Health Risks). (2008). Scientific opinion on the health effects of smokeless tobacco products, Belgium: Health & consumer protection DG, EuropeanCommission. Retrievedfromhttp://ec.europa.eu/health/archive/ ph-risk/committees/04-scenihr/ docs/scenihr-o-013.pdf
48. Scheffels, J., Lund, K., & McNeill, A. (2012). Contrasting snus and NRT as methods to quit smoking: An observational study. Harm Reduction Journal, 9, 10. doi:10.1186/1477-7517-9-10
49. Sponsiello-Wang, Z., Weitkunat, R., & Lee, P. N. (2008). Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America. BMC Cancer, 8, 356. doi:10.1186/1471- 2407-8-356
50. Stead, L. F., Bergson, G., & Lancaster, T. (2008). Physician advice for smoking cessation. Cochrane Database of Systematic Reviews, 2, CD000165. doi:10.1002/14651858.CD000165.pub3
51. Stepanov, I., Villalta, P. W., Knezevich, A., Jensen, J., Hatsukami, D., & Hecht, S. S. (2010). Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry. Chemical Research in Toxicology, 23, 66-73. doi:10.1021/tx900281u
52. Surgeon General. (1964). Smoking and health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. PHS Publication No. 1103. Washington DC, US GPO.
53. Teigen, K. H. (2001). Hvordan bedømmes risiko og sjanser I hverdagen? [How are risks and chances in everyday life judged?] In D. S. Thelle, G. Breivik, & G. Enebakk (Eds.), Pa den usikre siden: Risiko som forestilling, atferd og rettesnor. [On the unsafe side: Risk as conception, behaviour and guideline]. Oslo, Norway, Cappelen akademisk forlag.
54. Tomar, S. L. (2002). Snuff use and smoking in U.S. men: Implications for harm reduction. American Journal of Preventive Medicine, 23, 143-149. doi:10.1016/S0749-3797(02)00491-9
55. Wennberg, P., Eliasson, M., Hallmans, G., Johansson, L., Boman, K., & Jansson, J. H. (2007). The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. Journal of Internal Medicine, 3, 360-367. doi:10.1111/j.1365- 2796.2007.01813.x
56. Wikmans, T., & Ramström, L. (2010). Harm perception among Swedish daily smokers regarding nicotine, NRT-products and Swedish snus. Tobacco Induced Diseases, 13, 8-9. doi:10.1186/1617-9625-8-9